Cargando…

Molecular Insights into the In Vivo Analgesic and Anti-Inflammatory Activity of Indomethacin Analogues

[Image: see text] The primary objective of this research was to identify and explore the most potent and efficacious cyclooxygenase inhibitors, utilizing indole acetic acid drugs as a lead molecule. To achieve this objective, various derivatives (2a–2c and 2e–2g) of the selected lead molecule, indom...

Descripción completa

Detalles Bibliográficos
Autores principales: Ahmad, Abid Ali, Hussain, Kashif, Shah, Muhammad Raza, Ashhad Halimi, Syed Muhammad, Rabbi, Fazle, Ahmad, Zahoor, Khan, Inamullah, Rauf, Abdur, Alshammari, Abdulrahman, Alharbi, Metab, Rasul Suleria, Hafiz Ansar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2023
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10448495/
https://www.ncbi.nlm.nih.gov/pubmed/37636936
http://dx.doi.org/10.1021/acsomega.3c02033
_version_ 1785094746089193472
author Ahmad, Abid Ali
Hussain, Kashif
Shah, Muhammad Raza
Ashhad Halimi, Syed Muhammad
Rabbi, Fazle
Ahmad, Zahoor
Khan, Inamullah
Rauf, Abdur
Alshammari, Abdulrahman
Alharbi, Metab
Rasul Suleria, Hafiz Ansar
author_facet Ahmad, Abid Ali
Hussain, Kashif
Shah, Muhammad Raza
Ashhad Halimi, Syed Muhammad
Rabbi, Fazle
Ahmad, Zahoor
Khan, Inamullah
Rauf, Abdur
Alshammari, Abdulrahman
Alharbi, Metab
Rasul Suleria, Hafiz Ansar
author_sort Ahmad, Abid Ali
collection PubMed
description [Image: see text] The primary objective of this research was to identify and explore the most potent and efficacious cyclooxygenase inhibitors, utilizing indole acetic acid drugs as a lead molecule. To achieve this objective, various derivatives (2a–2c and 2e–2g) of the selected lead molecule, indomethacin, were synthesized using a reflux condensation process, targeting the hydroxyl group. The synthesized analogues were subjected to different spectroscopic procedures to determine their structure and confirm their analogues. These derivatives were further screened for acute toxicity and anti-nociceptive and anti-inflammatory activity using established protocols. Docking analysis was performed to evaluate the possible protein–ligand interaction. The test compounds were found to be safe at doses of 50, 75, 100, and 200 mg/kg, i.p. The pharmacological screening revealed that test compounds 2a–2f had a superior peripheral analgesic effect at a dose of 10 mg/kg, in comparison to the parent drug indomethacin, while compound 2g exhibited slightly lower activity at the same dose. The hot plate results showed lower central analgesic activity of the test compounds compared to the standard Tramal, but it was still significant. Anti-inflammatory results were significant, comparable to Diclofenac sodium and indomethacin, except for compounds 2b, 2c, and 2e at a dose of 10 mg/kg body weight. Molecular docking analysis demonstrated that the derived compounds had augmented negative binding energies (−149.39, −146.72, −160.85, −159.34, −140.03, and −150.91 KJ/mol) compared to the parent drugs (−141.07), which supported the research’s theme of producing stronger derivatives of standard drugs with significant anti-nociceptive and anti-inflammatory potential. The derived compounds exhibited significant analgesic and anti-inflammatory activities and, therefore, have the potential to be studied further as new drug candidates for pain and inflammation.
format Online
Article
Text
id pubmed-10448495
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher American Chemical Society
record_format MEDLINE/PubMed
spelling pubmed-104484952023-08-25 Molecular Insights into the In Vivo Analgesic and Anti-Inflammatory Activity of Indomethacin Analogues Ahmad, Abid Ali Hussain, Kashif Shah, Muhammad Raza Ashhad Halimi, Syed Muhammad Rabbi, Fazle Ahmad, Zahoor Khan, Inamullah Rauf, Abdur Alshammari, Abdulrahman Alharbi, Metab Rasul Suleria, Hafiz Ansar ACS Omega [Image: see text] The primary objective of this research was to identify and explore the most potent and efficacious cyclooxygenase inhibitors, utilizing indole acetic acid drugs as a lead molecule. To achieve this objective, various derivatives (2a–2c and 2e–2g) of the selected lead molecule, indomethacin, were synthesized using a reflux condensation process, targeting the hydroxyl group. The synthesized analogues were subjected to different spectroscopic procedures to determine their structure and confirm their analogues. These derivatives were further screened for acute toxicity and anti-nociceptive and anti-inflammatory activity using established protocols. Docking analysis was performed to evaluate the possible protein–ligand interaction. The test compounds were found to be safe at doses of 50, 75, 100, and 200 mg/kg, i.p. The pharmacological screening revealed that test compounds 2a–2f had a superior peripheral analgesic effect at a dose of 10 mg/kg, in comparison to the parent drug indomethacin, while compound 2g exhibited slightly lower activity at the same dose. The hot plate results showed lower central analgesic activity of the test compounds compared to the standard Tramal, but it was still significant. Anti-inflammatory results were significant, comparable to Diclofenac sodium and indomethacin, except for compounds 2b, 2c, and 2e at a dose of 10 mg/kg body weight. Molecular docking analysis demonstrated that the derived compounds had augmented negative binding energies (−149.39, −146.72, −160.85, −159.34, −140.03, and −150.91 KJ/mol) compared to the parent drugs (−141.07), which supported the research’s theme of producing stronger derivatives of standard drugs with significant anti-nociceptive and anti-inflammatory potential. The derived compounds exhibited significant analgesic and anti-inflammatory activities and, therefore, have the potential to be studied further as new drug candidates for pain and inflammation. American Chemical Society 2023-08-10 /pmc/articles/PMC10448495/ /pubmed/37636936 http://dx.doi.org/10.1021/acsomega.3c02033 Text en © 2023 The Authors. Published by American Chemical Society https://creativecommons.org/licenses/by-nc-nd/4.0/Permits non-commercial access and re-use, provided that author attribution and integrity are maintained; but does not permit creation of adaptations or other derivative works (https://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Ahmad, Abid Ali
Hussain, Kashif
Shah, Muhammad Raza
Ashhad Halimi, Syed Muhammad
Rabbi, Fazle
Ahmad, Zahoor
Khan, Inamullah
Rauf, Abdur
Alshammari, Abdulrahman
Alharbi, Metab
Rasul Suleria, Hafiz Ansar
Molecular Insights into the In Vivo Analgesic and Anti-Inflammatory Activity of Indomethacin Analogues
title Molecular Insights into the In Vivo Analgesic and Anti-Inflammatory Activity of Indomethacin Analogues
title_full Molecular Insights into the In Vivo Analgesic and Anti-Inflammatory Activity of Indomethacin Analogues
title_fullStr Molecular Insights into the In Vivo Analgesic and Anti-Inflammatory Activity of Indomethacin Analogues
title_full_unstemmed Molecular Insights into the In Vivo Analgesic and Anti-Inflammatory Activity of Indomethacin Analogues
title_short Molecular Insights into the In Vivo Analgesic and Anti-Inflammatory Activity of Indomethacin Analogues
title_sort molecular insights into the in vivo analgesic and anti-inflammatory activity of indomethacin analogues
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10448495/
https://www.ncbi.nlm.nih.gov/pubmed/37636936
http://dx.doi.org/10.1021/acsomega.3c02033
work_keys_str_mv AT ahmadabidali molecularinsightsintotheinvivoanalgesicandantiinflammatoryactivityofindomethacinanalogues
AT hussainkashif molecularinsightsintotheinvivoanalgesicandantiinflammatoryactivityofindomethacinanalogues
AT shahmuhammadraza molecularinsightsintotheinvivoanalgesicandantiinflammatoryactivityofindomethacinanalogues
AT ashhadhalimisyedmuhammad molecularinsightsintotheinvivoanalgesicandantiinflammatoryactivityofindomethacinanalogues
AT rabbifazle molecularinsightsintotheinvivoanalgesicandantiinflammatoryactivityofindomethacinanalogues
AT ahmadzahoor molecularinsightsintotheinvivoanalgesicandantiinflammatoryactivityofindomethacinanalogues
AT khaninamullah molecularinsightsintotheinvivoanalgesicandantiinflammatoryactivityofindomethacinanalogues
AT raufabdur molecularinsightsintotheinvivoanalgesicandantiinflammatoryactivityofindomethacinanalogues
AT alshammariabdulrahman molecularinsightsintotheinvivoanalgesicandantiinflammatoryactivityofindomethacinanalogues
AT alharbimetab molecularinsightsintotheinvivoanalgesicandantiinflammatoryactivityofindomethacinanalogues
AT rasulsuleriahafizansar molecularinsightsintotheinvivoanalgesicandantiinflammatoryactivityofindomethacinanalogues